{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:58Z","timestamp":1792513078482,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1019,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-53354"],"award-info":[{"award-number":["HL-53354"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-57516"],"award-info":[{"award-number":["HL-57516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-77428"],"award-info":[{"award-number":["HL-77428"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-63414"],"award-info":[{"award-number":["HL-63414"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-80137"],"award-info":[{"award-number":["HL-80137"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL-95874"],"award-info":[{"award-number":["HL-95874"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jacc.2010.05.039","type":"journal-article","created":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T04:57:35Z","timestamp":1285995455000},"page":"1287-1297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Rebuilding the Damaged Heart"],"prefix":"10.1016","volume":"56","author":[{"given":"Nirat","family":"Beohar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas W.","family":"Losordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2010.05.039_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.RES.85.3.221","article-title":"Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization","volume":"85","author":"Asahara","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nm740","article-title":"Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment","volume":"8","author":"Hattori","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.RES.86.12.1198","article-title":"Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects","volume":"86","author":"Kalka","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib4","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1073\/pnas.181177898","article-title":"Mobilized bone marrow cells repair the infarcted heart, improving function and survival","volume":"98","author":"Orlic","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2010.05.039_bib5","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/hc4201.097835","article-title":"Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study","volume":"104","author":"Seiler","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7434","article-title":"Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization","volume":"5","author":"Takahashi","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib7","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diabetes.50.6.1414","article-title":"IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress","volume":"50","author":"Kajstura","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2010.05.039_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/excr.1993.1202","article-title":"Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF1 autocrine system, enhanced expression of late growth related genes, DNA synthesis, and myocyte nuclear mitotic division in rats","volume":"207","author":"Reiss","year":"1993","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.RES.0000183733.53101.11","article-title":"Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival","volume":"97","author":"Urbanek","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.RES.0000013780.77774.75","article-title":"Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice","volume":"90","author":"Welch","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib12","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2010.05.039_bib13","doi-asserted-by":"crossref","first-page":"15885","DOI":"10.1073\/pnas.0907622106","article-title":"Identification of a coronary vascular progenitor cell in the human heart","volume":"106","author":"Bearzi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2010.05.039_bib14","doi-asserted-by":"crossref","first-page":"17169","DOI":"10.1073\/pnas.0903089106","article-title":"Clonality of mouse and human cardiomyogenesis in vivo","volume":"106","author":"Hosoda","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2010.05.039_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI12150","article-title":"Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells","volume":"107","author":"Jackson","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2010.05.039_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-0037-1615158","article-title":"Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation","volume":"80","author":"Wartiovaara","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2010.05.039_bib17","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood.V95.6.1993","article-title":"Identification of a family of alternatively spliced mRNA species of angiopoietin-1","volume":"95","author":"Huang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2010.05.039_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells","volume":"11","author":"Gnecchi","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/hc3501.093817","article-title":"Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines","volume":"104","author":"Kamihata","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tcm.2008.03.002","article-title":"Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease","volume":"18","author":"Kapur","year":"2008","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hc1102.105595","article-title":"Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris","volume":"105","author":"Grines","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib22","doi-asserted-by":"crossref","first-page":"24N","DOI":"10.1016\/S0002-9149(03)00965-2","article-title":"Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease","volume":"92","author":"Grines","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0735-1097(03)00988-4","article-title":"A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina","volume":"42","author":"Grines","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","article-title":"Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials","volume":"50","author":"Henry","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib25","doi-asserted-by":"crossref","first-page":"H352","DOI":"10.1152\/ajpheart.00621.2002","article-title":"Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis","volume":"285","author":"Matsunaga","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2010.05.039_bib27","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1172\/JCI117018","article-title":"Therapeutic angiogenesis","volume":"93","author":"Takeshita","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2010.05.039_bib28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cardiores.2006.11.030","article-title":"Stem cell-related cardiac gene expression early after murine myocardial infarction","volume":"73","author":"Vandervelde","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/eurheartj\/ehm542","article-title":"Enhanced functional response of CD133+ circulating progenitor cells in patients early after acute myocardial infarction","volume":"29","author":"Voo","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.05.039_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/10739680600556811","article-title":"Myocardial gene expression of angiogenic factors in human chronic ischemic myocardium: influence of acute ischemia\/cardioplegia and reperfusion","volume":"13","author":"Wang","year":"2006","journal-title":"Microcirculation"},{"key":"10.1016\/j.jacc.2010.05.039_bib31","first-page":"5687","article-title":"Expression of the vascular endothelial growth factor (VEGF) receptor gene KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation","volume":"55","author":"Katoh","year":"1995","journal-title":"Cancer Research"},{"key":"10.1016\/j.jacc.2010.05.039_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2010.05.039_bib33","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2010.05.039_bib34","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/01.RES.0000205765.28940.93","article-title":"CD34-\/CD133+\/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities","volume":"98","author":"Friedrich","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib35","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.CIR.89.5.2183","article-title":"Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs","volume":"89","author":"Banai","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib36","first-page":"H1791","article-title":"Vascular endothelial growth factor administration in chronic myocardial ischemia","volume":"270","author":"Harada","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0008-6363(98)00136-9","article-title":"VEGF administration in chronic myocardial ischemia in pigs","volume":"40","author":"Lopez","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib38","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm1095-1085","article-title":"Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis","volume":"1","author":"Pearlman","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1067\/mhj.2001.118471","article-title":"Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease","volume":"142","author":"Henry","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.05.039_bib40","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.98.25.2800","article-title":"Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia","volume":"98","author":"Losordo","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib42","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0003-4975(99)00807-3","article-title":"Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease","volume":"68","author":"Symes","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2010.05.039_bib43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.102.9.965","article-title":"Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia","volume":"102","author":"Vale","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib44","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/01.CIR.103.17.2138","article-title":"Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia","volume":"103","author":"Vale","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib45","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","article-title":"The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris","volume":"45","author":"Kastrup","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib47","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"Hedman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1537-2995.1999.39060555.x","article-title":"Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience","volume":"39","author":"Anderlini","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.jacc.2010.05.039_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI15994","article-title":"Disruption of the CXCR4\/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide","volume":"111","author":"Levesque","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2010.05.039_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2005.04.030","article-title":"Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction","volume":"150","author":"Kuethe","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.05.039_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm1199","article-title":"G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes","volume":"11","author":"Harada","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib52","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1096\/fj.05-4763fje","article-title":"G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis","volume":"20","author":"Deindl","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2010.05.039_bib53","first-page":"958","article-title":"Effects of recombinant murine granulocyte colony-stimulating factor on granulocyte-macrophage and blast colony formation","volume":"15","author":"Suda","year":"1987","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jacc.2010.05.039_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yjmcc.2005.05.012","article-title":"Signaling factors in stem cell-mediated repair of infarcted myocardium","volume":"39","author":"Vandervelde","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib55","first-page":"I73","volume":"112","author":"Ince","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib56","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIRCULATIONAHA.105.541433","article-title":"Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)","volume":"112","author":"Ince","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib57","first-page":"253","article-title":"[Effects of stem-cell mobilization with recombinant human granulocyte colony stimulating factor in patients with percutaneously revascularized acute anterior myocardial infarction]","volume":"58","author":"Suarez de Lezo","year":"2005","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib58","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/eurheartj\/ehi289","article-title":"Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile","volume":"26","author":"Valgimigli","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.05.039_bib59","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jacc.2006.07.044","volume":"48","author":"Engelmann","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib60","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/CIRCULATIONAHA.105.610469","volume":"113","author":"Ripa","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib61","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.295.9.1003","article-title":"Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial","volume":"295","author":"Zohlnh\u00f6fer","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2010.05.039_bib62","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2005.01.067","article-title":"Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease","volume":"46","author":"Hill","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib63","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2004.12.006","article-title":"Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease","volume":"100","author":"Wang","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib64","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(04)15689-4","volume":"363","author":"Kang","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.05.039_bib65","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ahj.2006.03.012","article-title":"Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction","volume":"151","author":"Steinwender","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.05.039_bib66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2005.05.024","article-title":"Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: a 12-month follow-up","volume":"109","author":"Boyle","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.20051151","article-title":"G-CSF\/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis","volume":"203","author":"Kuhlmann","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib68","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2004.05.083","article-title":"Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction","volume":"44","author":"Maekawa","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib69","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2006.06.014","article-title":"Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction","volume":"113","author":"Deng","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib70","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jacc.2005.01.068","article-title":"Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease","volume":"46","author":"Zbinden","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib71","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.4049\/jimmunol.181.8.5691","article-title":"Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction","volume":"181","author":"Naito","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jacc.2010.05.039_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jacc.2005.03.044","article-title":"Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction","volume":"46","author":"van der Meer","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib73","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","article-title":"Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization","volume":"102","author":"Heeschen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2010.05.039_bib74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejphar.2008.01.054","article-title":"Erythropoietin in cardiac disease: new features of an old drug","volume":"585","author":"Ruifrok","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2010.05.039_bib75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10557-006-7680-5","article-title":"A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study","volume":"20","author":"Lipsic","year":"2006","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2010.05.039_bib76","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ahj.2007.12.036","article-title":"Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III)","volume":"155","author":"Belonje","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2010.05.039_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/eje.0.1420211","article-title":"The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence","volume":"142","author":"Fazio","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacc.2010.05.039_bib78","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI117706","article-title":"Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure","volume":"95","author":"Duerr","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2010.05.039_bib79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0008-6363(98)00181-3","article-title":"Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction","volume":"40","author":"Grimm","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib80","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(97)11329-0","article-title":"Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy","volume":"351","author":"Osterziel","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.05.039_bib81","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(97)24015-8","article-title":"Haemodynamic effects of intravenous growth hormone in congestive heart failure","volume":"349","author":"Volterrani","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.05.039_bib82","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/euhj.1998.1123","article-title":"A placebo-controlled study of growth hormone in patients with congestive heart failure","volume":"19","author":"Isgaard","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2010.05.039_bib83","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM199603283341301","article-title":"A preliminary study of growth hormone in the treatment of dilated cardiomyopathy","volume":"334","author":"Fazio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.CIR.99.1.18","article-title":"Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity","volume":"99","author":"Genth-Zotz","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib85","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(05)62290-8","article-title":"Treatment of end-stage cardiac failure with growth hormone","volume":"349","author":"O'Driscoll","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.05.039_bib86","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.193.9.1005","article-title":"Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells","volume":"193","author":"Hattori","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib87","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.RES.0000218275.54089.12","article-title":"Signaling and functions of angiopoietin-1 in vascular protection","volume":"98","author":"Brindle","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib88","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","article-title":"Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions","volume":"87","author":"Gamble","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib89","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1525-0016(03)00230-2","article-title":"Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction","volume":"8","author":"Takahashi","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.jacc.2010.05.039_bib90","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11373-006-9082-x","article-title":"Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model","volume":"13","author":"Shim","year":"2006","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jacc.2010.05.039_bib91","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1073\/pnas.122109599","article-title":"Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF)","volume":"99","author":"Visconti","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2010.05.039_bib92","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cardiores.2006.08.002","article-title":"Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells","volume":"72","author":"Kim","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib93","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.105.086553","article-title":"Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage","volume":"314","author":"Roviezzo","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacc.2010.05.039_bib94","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0735-1097(00)00675-6","article-title":"Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function","volume":"36","author":"Yasuda","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib95","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1083\/jcb.119.3.629","article-title":"Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell mobility and growth","volume":"119","author":"Bussolino","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jacc.2010.05.039_bib96","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib97","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib98","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1006\/geno.1996.0098","article-title":"Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively","volume":"32","author":"Mattei","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.jacc.2010.05.039_bib99","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1538-7836.2003.00263.x","article-title":"Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders","volume":"1","author":"Autiero","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jacc.2010.05.039_bib100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2003.tb03232.x","article-title":"Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment","volume":"996","author":"Rafii","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacc.2010.05.039_bib101","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.atherosclerosis.2006.10.038","article-title":"Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization","volume":"196","author":"Pilarczyk","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2010.05.039_bib102","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jacc.2005.11.064","article-title":"Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction","volume":"47","author":"Iwama","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib103","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1540-8191.2006.00296.x","article-title":"Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy","volume":"21","author":"Kolakowski","year":"2006","journal-title":"J Card Surg"},{"key":"10.1016\/j.jacc.2010.05.039_bib104","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/CIRCULATIONAHA.104.495887","article-title":"Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation","volume":"111","author":"Khurana","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90302-U","article-title":"Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor","author":"Zsebo","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2010.05.039_bib106","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","article-title":"Stem cell factor and hematopoiesis","volume":"90","author":"Broudy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2010.05.039_bib107","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/335088a0","article-title":"The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus","volume":"335","author":"Chabot","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2010.05.039_bib108","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2010.05.039_bib109","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1096\/fj.07-8636com","article-title":"Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury","volume":"22","author":"Fazel","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2010.05.039_bib110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V88.1.75.75","article-title":"Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen","volume":"88","author":"Broudy","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2010.05.039_bib111","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature02460","article-title":"Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium","volume":"428","author":"Balsam","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2010.05.039_bib112","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2010.05.039_bib113","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.0000151843.79801.60","article-title":"Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion","volume":"96","author":"Kajstura","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib114","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1161\/01.CIR.0000167553.49133.81","article-title":"Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells","volume":"111","author":"Li","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib115","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2010.05.039_bib116","doi-asserted-by":"crossref","first-page":"H931","DOI":"10.1152\/ajpheart.01146.2002","article-title":"CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation","volume":"285","author":"Li","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib117","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cardiores.2004.08.019","article-title":"Cellular expression of integrin-beta 1 is of critical importance for inducing therapeutic angiogenesis by cell implantation","volume":"65","author":"Li","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib118","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/cvr\/cvm027","article-title":"Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells","volume":"77","author":"Lutz","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00395-007-0690-z","article-title":"Stem cell factor\/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK","volume":"103","author":"Kuang","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib120","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1182\/blood-2003-03-0685","article-title":"Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model","volume":"102","author":"Norol","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2010.05.039_bib121","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1096\/fj.03-0637fje","article-title":"Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization","volume":"18","author":"Ohtsuka","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2010.05.039_bib122","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000218454.76784.66","article-title":"Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function","volume":"98","author":"Dawn","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2010.05.039_bib123","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.0000129770.93985.3E","article-title":"Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment","volume":"109","author":"Minatoguchi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib124","first-page":"257","article-title":"Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing","volume":"69","author":"Beohar","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2010.05.039_bib125","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/hrt.2005.069799","article-title":"Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"92","author":"Wang","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2010.05.039_bib126","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(03)14232-8","article-title":"Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy","volume":"362","author":"Askari","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2010.05.039_bib127","first-page":"82","article-title":"Stem cell transplantation in myocardial infarction","volume":"5","author":"Lee","year":"2004","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib128","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.CIR.99.13.1726","article-title":"Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice","volume":"99","author":"Moulton","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib129","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1073\/pnas.0730843100","article-title":"Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis","volume":"100","author":"Moulton","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2010.05.039_bib130","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0735-1097(97)00049-1","article-title":"Passivation of metallic stents following arterial gene transfer of phVEGF165inhibits thrombus formation and intimal thickening","volume":"29","author":"Van Belle","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2010.05.039_bib131","first-page":"I353","article-title":"Influence of vascular endothelial growth factor on diabetic retinopathy","volume":"17","author":"Vale","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2010.05.039_bib132","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2010.05.039_bib133","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/sj.onc.1206197","article-title":"Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase\/Akt signaling","volume":"22","author":"Zhang","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jacc.2010.05.039_bib134","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<274::AID-IJC19>3.0.CO;2-2","article-title":"Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor\/scatter factor (HGF\/SF) in human glioma cells: HGF\/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP","volume":"82","author":"Hamasuna","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jacc.2010.05.039_bib135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI17034","article-title":"Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1","volume":"112","author":"Zhong","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2010.05.039_bib136","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1073\/pnas.95.11.6355","article-title":"CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth","volume":"95","author":"Babic","year":"1998","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109710027944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109710027944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:40:44Z","timestamp":1760013644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109710027944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":136,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0735109710027944"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2010.05.039","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebuilding the Damaged Heart","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2010.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}